Customer Center
Login | Register

Investor Relations

Investor Relations

Stock Information

More >>

Recent News

More >>
Date Title  
Toggle Summary Luminex Receives FDA 510(k) Clearance for the ARIES® MRSA Assay
  AUSTIN, Texas , Oct. 1, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced that the company has received U.S. Food and Drug Administration ( FDA ) 510(k) clearance for the ARIES ® MRSA Assay. The assay is an integrated, real-time, polymerase chain reaction (PCR) based, qualitative,
Toggle Summary Luminex Corporation to Present at the Cantor Global Healthcare Conference on October 2, 2019
  AUSTIN, Texas , Sept. 26, 2019 /PRNewswire/ --  Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir , President and Chief Executive Officer, and Harriss Currie , Senior Vice President of Finance and CFO, will participate in investor meetings and present at the Cantor Global